Aims & Scope
Journal of the Pakistan Dental Association (JPDA) is an internationally peer reviewed journal with high standards of publishing. It is aimed for publishing high quality papers of substantial content and interest in all branches of basic and clinical dentistry, i.e., Aesthetic dentistry, Endodontics, Orthodontics, Minimal Intervention Dentistry, Prosthodontics, Pediatric Dentistry, Preventive Dentistry, Periodontics, Oral and Maxillofacial Surgery, Dento-Maxillofacial Radiology, Oral Biology, Oral Pathology and Oral Medicine.
Journal of the Pakistan Dental Association is committed to publish rapidly to allow new research findings with potential global impact to be rapidly distributed among the readers in diverse areas of interest and expertise.
Ayyaz Ali Khan (View Profile)
BDS (Punjab), MSc (Wales), PhD (Ireland), MFGDP (UK)
CEO Institute of Advanced Dental Sciences and Research,
Title Abbreviation: J Pak Dent Assoc
ISSN (Print): 1680-2292
ISSN (Online): 2306-5885
Periodicity: Quarterly (4 issues per year)
Published by: Pakistan Dental Association (PDA)
Source of Revenue:
The sources of revenue of JPDA are as follows.
- Grant from Higher Education Commission Pakistan
- Publication Fee
- Pakistan Dental Association
Pakistan Dental Association is a non-profit corporation organized and registered under the laws of the Government of Pakistan.
The Pakistan Dental Association is an organization of dentists which has as its aim the encouragement of the health of the public and the promotion of the art and science of dentistry.
There are Branches of the Association in all States and a Provisional Branch in the Northern Territory. Membership is voluntary and over 90% of dentists in Pakistan are members.
This membership implies an obligation for members to practice their profession in accordance with the high standards laid down by the Association.
Functions of Pakistan Dental Association
- Maintain a national body representing organized dentistry in Pakistan; namely, the Central Council of the Pakistan Dental Association and its Executive Committee.
- Maintain a national headquarters for the Association.
- Maintain the records of Association activities and history.
- Maintain a continuing communication with the membership.
Manage the Association’s finances and maintain a continuing communication with the membership.
Journal of The Pakistan Dental Association
Journal of Pakistan Dental Association is the (JPDA) the official scientific journal of Pakistan Dental Association (PDA). It is indexed with index Medicus for WHO East Mediterranean Region (IMEMR). It is also recognized by PM&DC and HEC Pakistan. It is published quarterly. A double-blind peer review system is followed to ensure a high quality of publications. In addition to that, each publication undergoes a plagiarism check with Turnitin.
Sign-up as an Author
International Authors: US$ 200.00
JPDA publication charges details are as under:
A crossed cheque or a pay-order favouring Journal of The Pakistan Dental Association sent to the following address.
Journal of The Pakistan Dental Association
Instructions for Authors
Requirements for manuscripts submitted to JPDA
Potential Conflict of Interest:
The authors must declare any potential conflict of interest on a separate page.
The author must also declare the source of funding for the research project
The third declaration must be about access to study data and responsibility of author about integrity and accuracy of data analysis
Contribution made by each author should be declared on a separate page.
An author is a person who
Has significant contribution in conceiving and designing the study, and recording, analysis and interpretation of data.
Has written or critically reviewed the manuscript.
Has approved the final version.
Has agreed to be responsible for accuracy of results and integrity of the research.
All such contributors who do not fulfill all four criteria should be acknowledge separately.
All research projects that involve Human Subjects or pose serious threat to ecological system must get an approval from their respective Institutional Review Board before the commencement of study. If however, an IRB doesn’t exist in the parent institute, the author can take approval from another institute where this facility exists.
Clinical Trial Registration:
All clinical trials should be registered in a trial registry at the time or before enrolling the first patient.
Please follow the reporting guidelines for various study designs; e.g. CONSORT (www.consort-statement.org) for randomized trials, STROBE for observational studies (http://strobe-statement.org/), PRISMA for systematic reviews and meta-analyses (http://prisma-statement.org/), and STARD for studies of diagnostic accuracy (www.stard-statement.org/).
Sample Size Calculations:
Please use standard software for sample size calculation. Also mention the formula used, the estimate used for calculation and reference article from which the estimate is derived.
Submission Process (Online Only):
All submission should be through website (http://my.ejmanager.com/jpda/submit.php). All manuscripts should be accompanied by a letter from the author responsible for correspondence regarding the manuscript on behalf of his co-authors (if any). On receipt of the manuscript it will be initially assessed and, if having some merit for publication, an acknowledgement letter along with an author’s certification form will be sent to the correspondence author to proceed further.
Manuscripts submitted for publication in the JPDA should follow the instructions given below:
Please submit your manuscripts to JPDA in Microsoft Word version 97 or above . No manuscripts prepared in Word Perfect or other word processing software will be accepted. Also, no illustrations or other material prepared in Power Point will be accepted for review. If your material was prepared in Power Point, please copy it into a Microsoft Word document or submit it as a JPEG.
Manuscripts should be typed on 8 – 12 double-spaced on A-4 size papers (around 3000 words) with at least one-inch margins all around. Number all pages in sequence with the running title of the paper on each page.
Tables and illustrations should be submitted as a separate file. Identify statistical measures such as standard deviation and standard error of the mean. Make sure that each table, figure and photograph is cited in the text. Keep the number of each to the minimum needed.
Photographs must be submitted in electronic format (e.g. JPEG) of minimum 300 DPI. Please label them accordingly. (e.g. Picture no . 1, Pre-operative view). Permission must be obtained by the author for the use of any copyright material published previously. Any patient who is clearly identified in the article (either in text or in photographs) must sign a form indicating his or her consent to be thus depicted in the article. This consent form (PDF) must be submitted with the manuscript.
The manuscript, except for special communications and Guest Editorials should contain the following sections:
a) Title Page
Page 1 should include the title of the article and the name, degrees, title, professional / institutional affiliation and location of every author. Fax number, and email address must also be provided for the correspondence author. If the paper was presented at a meeting / conference or an organization / professional society, details of the conference etc, its location and dates, should be included.
b) Abstract / Key words
Page 2 should include a maximum of 250 words as a structured abstract
(i.e. Objective, Methodology, Results, Conclusion). Abstracts for case reports and literature reviews need not be structured. A list of 4-6 Key words should also be included.
Summarize the rationale and purpose of the study. It should neither review the subject extensively nor should it have data or conclusions. Give only pertinent references and clearly state the working hypothesis.
This section should be presented in sufficient detail to allow the reader to easily comprehend the methods used. Published methods should be referenced and discussed briefly unless some modifications have been made. If the method is new, give enough information so that other investigators are able to apply / use it. If a drug / material is used, its generic name, dose and route of administration / applications and manipulation, must be explained. Obtain ethical approvals and informed consents as required. For patients, gender and age (with their mean and standard deviation values) must be given. Indicate the statistical methods used if applicable.
Specify any computer programme used for analysis of the data. Any term that is frequently mentioned in the text can be abbreviated only if it does not detract from readers’ comprehension e.g. sub acute bacterial endocarditis (SBE). Do not start any new sentence with a figure
e.g. “40 patients were seen” should be written as “Forty patients were seen”. When using abbreviations, the full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement. Use generic terms whenever possible, but the trade names, manufacturer’s name and address should be included in parentheses at first mention.
Statistical Analysis: It is an integral part of methodology and should be written with clarity and enough details that any knowledgeable reader could verify the accuracy and appropriateness of the analysis and results. Where applicable, the findings should be presented in quantifiable terms and a point estimate and confidence interval reported. It is advised that only p values are not reported since they fail to convey important information such as effect size and precision. The software used for statistical analysis and its version should be mentioned.
Results should be presented clearly and logically as text, tables and illustrations. Do not repeat in the text all the data present in the tables or illustrations. Instead, a reference to the table or figure number can be given. Emphasize only important observations. Mention whether the hypothesis is accepted or rejected.
This should emphasize the present findings and variations from or similarities with other relevant studies. Point out the implications of the findings and the limitations of the study. Do not repeat in detail the data or other material given in the Introduction or Results sections.
Include a numeric listing of evidence-based conclusions.
Type on a separate page. Grant or other financial support, and commercial interests, should be specified.
Please use VANCOUVER style of referencing (http://www.nlm.nih.gov/bsd/uniform_requirements.html). All references given must be cited in the text and numbered in order of appearance in the manuscript. The reference list should be typed in numeric order with double-line spacing. It should start on a separate page after the main text of the manuscript. Do not include unpublished data or personal communications in the reference list. If essential, they can be included in the text with the details and dates shown in parentheses. Avoid using abstracts as references.
Provide complete information for each reference, including names and initials of all first six authors. If there are more than six authors, the remaining authors should be mentioned as “et al.”. The author name(s) and initials are followed by the title of the article, the name of the journal abbreviated according to the style followed in Index Medicus, year of publication, journal volume, and number of the first and last pages. e.g.:
Jamil M, Aboush YE, Elderton RJ. A comparative study of resin dentine bonding agents. J Pak Dent Assoc, 1991; 7: 69-77.
Reference for a chapter or part of a book should have author name(s) and initials, full title of the chapter or part, name of the editor(s), complete title of the book, city address, publisher, year of publication and the number of the first and last pages. e.g.:
Zaidi SH. Oral cancer. In: Jalisi M, Jazbi B (eds). Current problems in otorhinolaryngology. Karachi: Doctor Publication, 1991: 259-285.
J) Continuing Education
On a separate page(s) 4-6 objective, multiple choice (MC) or true / false (T/F) type questions should be supplied for readers. The questions must be double-spaced and have four selections, (a) through (d), with correct answers indicated.
Review Process: JPDA is a peer-reviewed journal. All articles on receipt for publication are acknowledged, but it does not mean that the article is accepted for publication. As per HEC / PMDC rule the MS is subjected to plagiarism check. Similarity index above 19% will not be acceptable for publication. The article is sent to two reviewers who take about 4 – 8 weeks to review the article. The ultimate authority to accept or reject the manuscript rests with the Editor. Confidentiality of the author(s) is maintained. On receipt of the comments from reviewer and, if the article is approved, a letter of acceptance is issued to the author stating the likely date of publication. JPDA reserves the right to edit all communications. If required, clarifications or changes are sought from the correspondence author. No article is rejected unless two of the reviewers reject it.
Proof Reading: A formatted PDF version of the manuscript will be sent to the author for proofing. Please indicate corrections/changes in the PDF using the sticky note and highlight text option in Adobe Reader XI or above. This version of Adobe Reader is freely available.
Journal of the Pakistan Dental Association (JPDA) follows the uniform requirements for manuscripts submitted to Biomedical Journals as approved by the International Committee of Medical Journal Editors revision of December 20-17 available at http://www.icmje.org/icmje-recommendations.pdf. The ethical declaration for JPDA is based on the ‘Code of Conduct’ guidelines by the Committee on Publication Ethics (COPE) available at www.publicationethics.org.
Journal of Pakistan Dental Association is the (JPDA) the official scientific journal of Pakistan Dental Association (PDA). It is published quarterly. Whereas, the Dental News are its composer and publisher. A double-blind peer review system is followed to ensure a high quality of publications. In addition to that, each publication undergoes a plagiarism check with Turnitin.
All rights are reserved. No part of this journal may be reproduced, stored in a retrieval system, transmitted in any form, or by any other means; electronic, mechanical, photocopying, recording or otherwise, except for internal or personal use, without the prior permission, in writing, from the Journal of Pakistan Dental Association.
All submissions are accompanied by a statement from the author that their paper has not been submitted for publication elsewhere nor has been published before. Also, that all authors have read the and approved the final draft for publication and bear full responsibility.
The publisher and editorial board shall not be held accountable for consequences resulting from misuse of information published in this journal. Whereas, the content published in the journal represents the opinions of author only and not that of publisher or editorial board, the editorial board reserves the right to amend or remove part or whole of manuscripts if deemed necessary.
PEER RERIEW PROCESS
1. In-House Review
Each submission undergoes an in-house review. In this step, scope of paper, plagiarism and completeness of obligatory documents is checked.
2. Peer Review
We follow a double-blind peer review. Our reviewers belong to national and international educational and research institutes. Each submission is sent to al-least two reviewers. The reviewers are given an average of three weeks to submit their report. The comments of reviewers are forwarded to authors and once revised manuscript is received from the authors, it is sent back to the original or a new set of reviewers for a re-review. Once a cycle of review and re-review is complete and reviewers are satisfied with the quality of manuscript, an acceptance is issued.
3. Malpractice Statement
Manuscripts, either published or under review will be withdrawn and rejected if a part or whole of it was determined to violate the publishing ethics guidelines such as multiple submission, fake claims of authorship, plagiarism, fraudulent use of data or the like. Moreover, such an author may be black listed and banned from future submission for a period determined by the editorial board.
4. Plagiarism Prevention
JPDA uses the standard software (Turnitin) to detect instances of overlapping and similar text in submitted manuscripts. The software checks content against a database of periodicals, the Internet, and a comprehensive articles database. It generates a similarity report, highlighting the percentage of overlap between the uploaded article and the published material. Any instance of content overlap is further scrutinized for suspected plagiarism according to the publisher’s Editorial Policies. JPDA allows an overall similarity of 19% for a manuscript to be considered for publication.
ETHICAL APPROVAL OF STUDIES AND INFORMED CONSENT
For human or animal experimental investigations, it is a prerequisite to provide a formal approval, by an appropriate institutional review board or ethics committee, which should be documented in the paper. For investigations undertaken on human subjects, the manner in which the informed consent was obtained from the study participants (i.e., oral or written) should be stated in the Methods section. All clinical investigations must be conducted according to the Declaration of Helsinki principles.
APPEALS AND COMPLAINTS
Authors who wish to make a complaint should refer it to the Editor-in-Chief of the journal. (email@example.com)
Complaints to the Publisher may be forwarded to firstname.lastname@example.org
CONFLICT OF INTEREST
Financial and intellectual contributions to the work being reported should be clearly acknowledged, as should any potential conflict of interest.
ERRATA AND CORRECTIONS IN PUBLISHED ARTICLES
Authors and readers are encouraged to notify the Editor-in-Chief if they find errors in published content, authors’ names and affiliations or if they have reasons for concern over the legitimacy of a publication. In such cases the journal will publish an ERRATUM in consultation with Editor-in-Chief and authors of the article in the next issue, and/or replace or retract the article.